🔴 Achieve Life Sciences is trading 5% down

Achieve Life Sciences is trading 5.05% down at $7.15; no confirmed company-specific news explains the October 2 decline.

• Latest announcements were a CFO appointment on October 1 and a planned presentation of 52-week cytisinicline data; neither is an evident negative catalyst.
• The broader market is higher, supported by weaker-than-expected U.S. jobs data, which does not explain the stock’s move lower.
• The prior close was $7.53 on October 1, down 6.92%, continuing recent weakness.